Gln-AMS TFA

谷氨酰胺一氨甲基磺酸三氟乙酸

Gln-AMS TFA

G659261-5mg

5mg

≥98%

-20°C储存,充氩

超低温冰袋运输

Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. Gln-AMS inhibits glutaminyl-tRNA synthetase (GlnRS) with a K i of 1.32 µM. Appearance:Solid IC50& Target:Ki: 1.32 µM (GlnRS) In Vitro:Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Biological Activity:Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. Gln-AMS inhibits glutaminyl-tRNA synthetase (GlnRS) with a K i of 1.32 µM.

C17H23F3N8O10S

588.47 g/mol

NC1=C2N=CN([C@@H]3O[C@H](COS(=O)(NC([C@@H](N)CCC(N)=O)=O)=O)[C@@H](O)[C@H]3O)C2=NC=N1.OC(C(F)(F)F)=O

H2O : 130 mg/mL (220.91 mM; Need ultrasonic) DMSO : 50 mg/mL (84.97 mM; ultrasonic and warming and heat to 60°C)